GridAI Share Price

GridAI Share Price

NASDAQ: GRDX | Micro Cap | Utilities
$3.22
-$0.11 (-3.45%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

GridAI Stock Performance

Open
$3.52
Prev. Close
$3.33
Circuit Range
N/A
Day Range
$3.15 - $3.52
Year Range
$1.87 - $6.83
Volume
5,177
Average Traded
$3.25

GridAI Share Price Today

As of 21 November 2026, GridAI Technologies Corp.'s share price is $3.22. The stock opened at $3.52, compared to its previous close of $3.33. During today's trading session, GridAI Technologies Corp.'s share price traded between $3.15 and $3.52, with an average price of $3.33. Over the past 52 weeks, the stock has recorded a high of $6.83 and a low of $1.87. In terms of performance, GridAI Technologies Corp.'s share price has declined by 41.88% over the last six months and is down 28.29% on a year-on-year basis.

GridAI Share Price Chart

Line chart of the GridAI price trend over the selected period. The price fell overall, ranging from 3.15 to 3.54, ending at 3.22.
$3.15$3.52
L
Show Current Price
H

GridAI Stock Fundamentals & Key Indicators

Market Cap
$11.06M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.21
Revenue (TTM)
$40.00M
Return On Equity (TTM)
-207.04%
Profit Margin
-16825.00%
Debt to Equity
0.17
Quarterly Earnings Growth YoY
-1.63%

GridAI Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.04$0.04$0.09$0.04
Net Profit-$3.07-$3.63-$12.90-$3.12
Net Profit Margin-7675.00%-9075.00%-14333.33%-7800.00%
Income ChangeN/A-18.24%-255.37%75.81%

GridAI Annual Profit & Loss

All figures in USD

Particulars2025
Revenue$0.04
Net Profit-$6.73
Net Profit Margin-16825.00%
Income ChangeN/A

GridAI Balance Sheet

All figures in USD Million

Particulars2025
Non Current Assets45.96
Current Assets2.6
Total Assets48.55
Non Current Liabilities4.56
Current Liabilities15.16
Total Liabilities19.72
Shareholders' Equity24.94

GridAI Cash Flow

Annually

All figures in USD Million

Particulars2025
Operating-5.7
Investing0.32
Financing5.89

Corporate Actions

Split
Ex-date: 18 Aug 2025

About GridAI

GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.

GridAI Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$4.83
$3.23
-34.68%
Oct 2026
$3.43
$4.95
+31.87%
Sep 2026
$3.79
$3.75
-6.25%
Aug 2026
$2.94
$4.00
+35.14%
Jul 2026
$4.69
$2.96
-36.07%
Jun 2026
$6.11
$4.63
-16.43%
May 2026
$2.47
$5.54
+118.97%
Apr 2026
$2.10
$2.53
+25.56%
Mar 2026
$2.33
$2.02
-14.98%
Feb 2026
$3.17
$2.37
-24.52%
Jan 2026
$4.54
$3.14
-30.07%
Dec 2025
$2.65
$4.49
N/A

GridAI Share Price FAQs